MIRACULINS INC has a total of 15 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are AURELIUM BIOPHARMA INC, AYTU BIOSCIENCE INC and BORREBAECK CARL ARNE KRISTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Yilan | 12 |
#2 | Barker Douglas | 12 |
#3 | Stedronsky Katrin | 8 |
#4 | Frost Stephen | 6 |
#5 | Atnikov Katrin | 4 |
#6 | Horsewood Peter | 2 |
#7 | Zawydiwski Robert | 2 |
#8 | Dun Ted | 1 |
#9 | Evelegh Michael | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014015439A1 | Titration of therapy through assay of cholesterol in skin by mass spectroscopy | |
CA2747184A1 | Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population | |
WO2011150517A2 | Xyxin fragment biomarker for diagnosis of colon cancer | |
CA2750062A1 | Diagnostic assays for prostate cancer using psp94 and psa biomarkers | |
WO2008110006A1 | Biomarkers of prostate cancer and uses thereof | |
US2008020940A1 | Biomarkers for use in the diagnosis and treatment of colorectal cancer |